CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Global Cord Blood Corp Company Snapshot
Global Cord Blood Corp operates in the Health and allied services sector. In addition to historical fundamental analyses, the complete report available to purchase compares Global Cord Blood Corp with three other health care providers in Asia: Green Cross Lab Cell Corp of KOREA (SOUTH) (2020 sales of 85.56 billion Korean Won [US$76.66 million] of which 72% was Clinical Laboratory Services), Human Health Holdings Ltd of HONG KONG (453.74 million Hong Kong Dollars [US$58.46 million] of which 59% was General practice services), and Cordlife Group Limited which is based in SINGAPORE (50.62 million Singapore Dollars [US$38.17 million] of which 95% was Banking).

Sales Analysis. During the third fiscal quarter of 2021, sales at Global Cord Blood Corp totalled 290.80 million Chinese Renmimbi. This is a drop of 13.1% from the 334.73 million Chinese Renmimbi in sales at the company during the third quarter in 2020. This was the biggest quarterly decline in sales at Global Cord Blood Corp in the previous 36 quarters. During the first three quarters of 2021, sales totalled 857.32 million Chinese Renmimbi, which is 7.0% lower than through the first three fiscal quarters of 2020. Global Cord Blood Corp reported sales of 1.22 billion Chinese Renmimbi (US$190.94 million) for the fiscal year ending March of 2020. This represents an increase of 23.8% versus 2019, when the company's sales were 986.75 million Chinese Renmimbi. Sales at Global Cord Blood Corp have increased during each of the previous five years (and since 2015, sales have increased a total of 92%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Global Cord Blood Corp
  Stock Performance Chart for Global Cord Blood Corp
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 36.08
(Figures in Chinese Renmimbi)
1 Week -5.8%   13 Weeks 12.1%  
4 Weeks 21.3%   52 Weeks 67.6%  
 
Global Cord Blood Corp Key Data:
  Ticker: CO Country: Hong Kong
  Exchanges: NYSE Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2020 Sales 1,221,460,000
(Year Ending Jan 2021).
Employees: 1,260
  Currency: Chinese Renmimbi Market Cap: 4,385,450,959
  Fiscal Yr Ends: March Shares Outstanding: 121,551,075
  Share Type: Gu Closely Held Shares: 86,819,229
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.